Who owns the ANKTIVA THE NK CELL GROWTH FACTOR trademark?

The ANKTIVA THE NK CELL GROWTH FACTOR trademark is owned by ImmunityBio, Inc..

What class is the ANKTIVA THE NK CELL GROWTH FACTOR trademark registered in?

The ANKTIVA THE NK CELL GROWTH FACTOR trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ANKTIVA THE NK CELL GROWTH FACTOR?

The USPTO serial number for ANKTIVA THE NK CELL GROWTH FACTOR is 99527269.

What is the registration number for ANKTIVA THE NK CELL GROWTH FACTOR?

ANKTIVA THE NK CELL GROWTH FACTOR is registered under USPTO registration number 0.

ANK

USPTO Trademark Record

PENDING

ANKTIVA THE NK CELL GROWTH FACTOR

SN 99527269·Reg 0·Filed Dec 03, 2025

Owner ImmunityBio, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ANKTIVA THE NK CELL GROWTH FACTOR (Serial No. 99527269), Registration No. 0, is a pending US trademark filed on Dec 03, 2025 by ImmunityBio, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Statement of Use due: March 08, 2027152 days remaining

Mark Intelligence

ANKTIVA THE NK CELL GROWTH FACTOR (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 03, 2025

SERIAL

99527269

REG#

Owner

Applicant

ImmunityBio, Inc.

Entity

Corporation

State

Address

3530 John Hopkins Court, San Diego, CA, 92121

Country

Attorney

NameAlicia M. Passerin

Law firm

Alicia M. Passerin Leech Tishman Fuscaldo & Lampl

Docket

IBIO-143

Address

525 William Penn Place, 28th Floor, Pittsburgh, PA 15219, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateDec 03, 2025

Serial Number99527269

Registration No.0

Status DateSep 08, 2026

Published for OppositionJul 14, 2026

Mark TypeStandard characters

Attorney DocketIBIO-143

Status DescriptionLive and pending, notice of allowance issued

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

15 events

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 08, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 14, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Jul 14, 2026

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 08, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 18, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 16, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 16, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 16, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Mar 16, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 16, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 16, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 13, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Dec 03, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Dec 03, 2025

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 03, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ANKTIVA THE NK CELL GROWTH FACTOR

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by ImmunityBio, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Alicia M. Passerin

Resources

Company